The second European collaborative study on the frequency of antimicrobial resistance inHaemophilus influenzae
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
In the second European survey of the prevalence of antimicrobial resistance inHaemophilus influenzae, 2529 clinical isolates collected in 1988/89 from 78 laboratories in nine countries (Austria, Belgium, Federal Republic of Germany, France, Italy, The Netherlands, Spain, Switzerland, United Kingdom) were examined. Of these, 23.8 % were type b strains. The overall rate of beta-lactamase production was 9.1 %, being slightly higher in type b isolates (10.5 %) compared to non-type b isolates (8.6 %). The MICs of six antimicrobials (ampicillin, cefaclor, chloramphenicol, erythromycin, tetracycline, and cotrimoxazole) were determined by an agar dilution procedure at a single central laboratory. The proportion of isolates resistant to the antimicrobials varied considerably amongst the individual countries. The highest incidence of resistance to all six drugs was observed in strains collected in Spain, whereas resistance was rarely encountered among strains isolated in Austria and the FRG. Resistance to ampicillin (MIC ≥ 4 mg/l) among strains that lacked beta-lactamase activity was uncommon (0.3 %). Based on the NCCLSHaemophilus influenzae breakpoints, the rates of susceptibility and resistance to cefaclor, chloramphenicol, tetracycline, and cotrimoxazole were 96.4/1.5, 96.2/2.8, 92.4/4.7, and 87.9/7.3 %, respectively. The rate of susceptibility and resistance to erythromycin was 2.3/19.9. Multiple resistance to ampicillin, chloramphenicol, tetracycline, and cotrimoxazole was observed in 15 isolates (0.6 %), and resistance to three drugs simultaneously in 72 (1.5 %). The incidence of beta-lactamase producing strains was similar to that seen in the first European study performed in 1986 (9.1 % vs. 10.9 %), and was half that observed in US isolates collected in 1986. On the other hand, strains isolated in the USA rarely showed resistance to cotrimoxazole (0.3 %), whereas in the European isolates, the frequency of resistance to this drug combination was 7.3 %.
- Gunn BA, Woodall JB, Jones JF, Thornsberry C: Ampicillin-resistantHaemophilus influenzae. Lancet 1974, ii: 845.
- Thomas WJ, McReynolds JW, Mock CR, Bailey EW: Ampicillin-resistantHaemophilus influenzae meningitis. Lancet 1974, i: 313.
- Tomeh M, Starr SE, McGowan JE, Terry PM, Nahmias AJ: Ampicillin-resistantHaemophilus influenzae type b infection. Journal of the American Medical Association 1974, 229: 295–297.
- Howard AJ, Hince CJ, Williams CD: Antibiotic resistance inStreptococcus pneumoniae andHaemophilus influenzae. British Medical Journal 1978, i: 1657–1660.
- Philpott-Howard J, Williams JD: Increase in antibiotic resistance inHaemophilus influenzae in the United Kingdom since 1977: report of a study group. British Medical Journal 1982, 284: 1597–1599.
- Powell M, Koutsia-Carrouzou C, Voutsinas D, Scymour A, Williams JD: Resistance of clinical isolates ofHaemophilus influenzae in the United Kingdom 1986. British Medical Journal 1987, 295: 176–179.
- Doern GV, Jorgensen JH, Thornsberry C, Preston DA, andthe Haemophilus influenzae Surveillance Group: Prevalence of antimicrobial resistance among clinical isolates ofHaemophilus influenzae: a collaborative study. Diagnostic Microbiology and Infectious Diseases 1986, 4: 95–107.
- Doern GV, Jorgensen JH, Thornsberry C, Preston DA, Tubert T, Redding JS, Maher LA: National collaborative study of the prevalence of antimicrobial resistance among clinical isolates ofHaemophilus influenzae. Antimicrobial Agents and Chemotherapy 1988, 32: 180–185.
- Reid AJ, Simpson IN, Harper PB, Amyes SGB: Ampicillin resistance inHaemophilus influenzae: identification of resistance mechanisms. Journal of Antimicrobial Chemotherapy 1987, 20: 645–656.
- Dabernat H, Delmas C, Lareng MB: Prévalence de la résistance aux antibiotiques desHaemophilus influenzae isolès en France: un an d'activité du réseau de surveillance des infections àHaemophilus influenzae. Pathologie Biologie 1986, 34: 372–378.
- Machka K, Braveny I, Dabernat H, Dornbusch K, Van Dyck E, Kayser FH, Van Klingeren B, Mittermayer H, Perea E, Powell M: Distribution and resistance patterns ofHaemophilus influenzae: a European cooperative study. European Journal of Clinical Microbiology and Infectious Diseases 1988, 7: 14–24.
- Manten A, Van Klingeren B, Dessens-Kroon M: Chloramphenicol resistance inHaemophilus influenzae. Lancet 1976, i: 702.
- Campos J, Garcia-Tornel S, Sanfeliu I: Susceptibility studies of multiply resistantHaemophilus influenzae isolated from pediatric patients and contacts. Antimicrobial Agents and Chemotherapy 1984, 25: 706–709.
- Braveny I, Machka K, Bartmann K, Fabrizius K, Peter KF, Grimm H, Ullmann U, Freiesleben H: Antibiotikaresistanz vonHaemophilus influenzae in der Bundesrepublik Deutschland. Deutsche Medizinische Wochenschrift 1980, 105: 1341–1344.
- Kilian M:Haemophilus. In: Lennette EH, Balows A, Hausler WJ, Shadomy HJ (ed): Manual of clinical microbiology. American Society for Microbiology, Washington DC, 1985, p. 387–393.
- Schoenknecht FD, Sabath LD, Thornsberry C: Susceptibility tests: special tests. In: Lennette EH, Balows A, Hausler WJ, Shadomy HJ (ed): Manual of clinical microbiology. American Society for Microbiology, Washington DC, 1985, p. 1006.
- National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard M7-A2. NCCLS, Villanova, PA, 1990.
- Mendelman PM, Wiley EA, Stull TL, Clausen C, Chaffin DO, Oenay O: Problems with current recommendations for susceptibility testing ofHaemophilus influenzae. Antimicrobial Agents and Chemotherapy 1990, 34: 1480–1484.
- Jorgensen JH, Redding JS, Maher LA, Howell AW: Improved medium for antimicrobial susceptibility testing ofHaemophilus influenzae. Journal of Clinical Microbiology 1987, 25: 2105–2113.
- Kayser FH, Morenzoni G, Homberger F: Activity of cefoperazone against ampicillin-resistant bacteria in agar and broth dilution tests. Antimicrobial Agents and Chemotherapy 1982, 22: 15–22.
- Reid AJ, Simpson IN, Herper PB, Amyes SGB: Ampicillin resistance inHaemophilus influenzae: identification of resistance mechanisms. Journal of Antimicrobial Chemotherapy 1987, 20: 645–656.
- Powell M, Williams JD: In-vitro activity of cefaclor, cephalexin and ampicillin against 2458 clinical isolates ofHaemophilus influenzae. Journal of Antimicrobial Chemotherapy 1988, 21: 27–31.
- Howard AJ, Williams HM: The prevalence of antibiotic resistance inHaemophilus influenzae in Wales. Journal of Antimicrobial Chemotherapy 1988, 21: 251–260.
- The second European collaborative study on the frequency of antimicrobial resistance inHaemophilus influenzae
European Journal of Clinical Microbiology and Infectious Diseases
Volume 9, Issue 11 , pp 810-817
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Industry Sectors